These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26475482)

  • 1. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
    Zheng F; Zha H; Yang D; Deng J; Zhang Z
    Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
    Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
    J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
    Zeng SY; Liu T; Meng WT; Chen YN
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
    J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
    Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
    APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple serum antigenic assays for diagnosis of invasive fungal infections in non-neutropenic adult patients].
    Jin J; Sun TY; Hu YJ; Li YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):660-4. PubMed ID: 21092632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.
    Ellis M; Al-Ramadi B; Finkelman M; Hedstrom U; Kristensen J; Ali-Zadeh H; Klingspor L
    J Med Microbiol; 2008 Mar; 57(Pt 3):287-295. PubMed ID: 18287290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
    Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
    Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
    Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
    Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
    Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
    Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
    Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
    Metan G; Ağkuş C; Buldu H; Koç AN
    Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
    Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
    J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.